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Abstracts: The mouse Flk1 (also called Kdr or Vegf-r2) gene encodes a receptor for VEGF-A.  
Flk1 is expressed in endothelial cells of the developing embryo.  Recent studies have shown 
that Flk1 is expressed by multi-potent mesodermal progenitors, which give rise to various 
hematopoietic and cardiovascular cell lineages during development, and in differentiating 
ES cells, which may be used for cell transplantation therapy to treat cardiovascular diseases.  
Given its developmental and clinical importance in cardiovascular tissues, an animal model 
of Flk1 activity would be very useful.  Here, we report the generation of Flk1-GFP BAC 
transgenic mice for monitoring Flk1 gene expression during development.  We show that 
GFP expression in these mice serves as a surrogate marker for developing endothelial cells.  
Immunohistochemical analysis showed that the regions of expression of GFP and endogenous 
FLK1 largely overlap.  Uniform GFP expression was observed in most endothelial cells at 
8.5 dpc and thereafter.  Flk1-GFP BAC transgenic mice should be useful for the study of both 
vascular development and pathological angiogenesis.
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Introduction
The mouse Flk1 gene encodes a receptor for vascular 
endothelial growth factor A (VEGF-A) [5].  During the 
later stages of embryonic development, Flk1 is expressed 
abundantly in endothelial cells [17].  Gene targeting 
experiments have shown that Flk1-deficient mice die 
between 8.5 and 9.5 days postcoitum (dpc) due to the 
absence of blood vessels and blood islands [15].  Recent 
studies have shown that Flk1-positive progenitor cells 
are multi-potential, and can differentiate into smooth 
muscle cells and cardiomyocytes in addition to he-
matopoietic and endothelial lineages during mouse de-
velopment and ES cell differentiation [2, 3, 9, 12, 13, 
16, 18].  Importantly, these properties have been ob-
served in both mouse and human ES cells in in vitro 
differentiation models [19].
In the adult, Flk1 is expressed at a low level in normal 
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vascular beds, but is expressed more strongly in the neo-
vasculature associated with tumor formation [5].  VEGF-
A signaling is an important regulatory pathway control-
ling tumor angiogenesis.  Although our understanding 
of the process of angiogenesis has grown, the precise 
molecular and cellular mechanisms of vascular develop-
ment are still poorly understood.  Therefore, the genera-
tion of an animal model of Flk1 gene activity should lead 
to a better understanding of these processes, and should 
also be useful for the development of more effective 
approaches for treating conditions such as cancer that 
depend on angiogenesis.
Kappel and coworkers identified an enhancer activity 
in the first intron of the Flk1 gene, which directs Flk1 
expression in endothelial cells of the yolk sac region at 
7.5 dpc [7, 8].  This enhancer was successfully used to 
drive mCherry expression in endothelial cells by other 
researchers [11, 14].  However, deletion of this enhanc-
er has no significant effect upon Flk1 expression in me-
sodermal progenitors at 7.5 dpc or in endothelial cells 
at 8.5 dpc [3].  These results suggest that an as-yet un-
identified enhancer directs Flk1 expression in endothe-
lial cells and early mesodermal cells.
Here, we report the generation of Flk1-GFP BAC 
(bacterial artificial chromosome) transgenic mice to 
monitor Flk1 gene expression during development.  Im-
munohistochemical analysis showed that the distribution 
of expression of GFP (green fluorescent protein) and 
endogenous FLK1 significantly overlapped.  Uniform 
GFP expression was observed in most endothelial cells 
at 8.5 dpc and thereafter.  Thus, the Flk1-GFP BAC 
transgenic mice generated in this study should be useful 
for studying vascular development and pathological an-
giogenesis.
Materials and Methods
Construction of the Flk1-GFP transgene
BAC clones covering the Flk1 locus were obtained 
from Invitrogen.  One clone (RP24-125B24) was modi-
fied using the RED/ET recombination technique (Gene 
Bridges, Heidelberg, Germany).  A DNA fragment en-
coding GFP-SV40 polyA (Clontech, Mountainview, CA, 
USA) was ligated to a DNA fragment encoding an FRT 
PGK-gb2-neo expression cassette comprised of a 
prokaryotic promoter and neomycin-resistance gene 
flanked by FRT sequences (Gene Bridges).  Homology 
arms for the first exon of Flk1 were ligated to both ends 
of the reporter cassette by PCR amplification.  Escheri-
chia coli carrying the BAC were transformed with a 
RED/ET expression plasmid, pSC101-BAD-gbaA.  Re-
combinants were identified by screening for kanamycin 
resistance followed by PCR analysis.  The Kan/Neo cas-
sette was excised by inducing FLPe expression after 
introduction of the FLPe expression plasmid (Gene 
Bridges).
Generation of transgenic animals
Recombinant BAC DNAs were purified using a 
BAC100 column (Nippon Genetics, Tokyo, Japan) and 
linearized by Pl-Scel digestion.  Fertilized eggs collected 
from BDF1 females were used for pronuclear injection, 
and the injected eggs were transplanted into pseudo-
pregnant ICR females (SLC Inc., Shizuoka, Japan).  The 
mice were maintained on an ICR genetic background. 
Flk1-GFP BAC Tg animals were genotyped and dis-
criminated from Flk1-GFP knock-in animals by a pair of 
primers: 5’-GTTCCTATACTTTCTAGAGAAATGG-3’, 
5’-GAGTTATTTAGTTTAATACACC-3’.  Fluorescent 
images of the whole body were taken by a VB7010 mi-
croscope (Keyence).  This study was approved and con-
ducted in accordance with the Regulations for Animal 
Experimentation of the University of Tsukuba.
Immunohistochemistry
Embryos were dissected, staged according to the 
method of Downs and Davies [1], and fixed with 4% 
paraformaldehyde (PFA) overnight.  After washing with 
PBS, the embryos were soaked in 30% sucrose, mount-
ed on OCT compound, and then 4 mm cryosections were 
prepared.  Immunohistochemistry was performed with 
anti-FLK1 (clone AVAS12; BD) and anti-GFP (rabbit 
polyclonal; MBL), as previously described [4].  In brief, 
after blocking in PBSMT (PBS + 2% skim milk + 0.1% 
tween20) for 1 h, the sections were incubated with the 
first antibodies at 4°C overnight.  The sections were 
washed twice in PBST for 5 min and then incubated with 
fluorochrome-conjugated secondary antibodies at room 
temperature for 1 h.  Nuclei were visualized by incuba-
tion with 2 mg/ml Hoechst 33342 for 10 min at room 
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temperature and the sections were mounted in Perma-
Fluor Mounting medium (Thermo Electron Corp., Pitts-
burgh, PA, USA).  The images were captured by a Leica 
DC500 digital camera system.  Whole mount immuno-
histochemistry was performed and Cy3-conjugated anti-
rat antibody (Jackson Immunological, West Grove, PA, 
USA) was used as the 2nd antibody.  Leica confocal 
microscopy SP5 or BioRevo (Keyence, Osaka, Japan) 
was used for imaging.
Mouse aortic ring assay
Thoracic aortas were removed from Flk1-GFP BAC 
Tg mice and immediately transferred to a culture dish 
containing serum-free Dulbecco’s Modified Eagle Me-
dium (Invitrogen, Carlsbad, CA, USA).  The peri-aortic 
fibroadipose tissue was carefully removed with fine mi-
crodissecting forceps and iridectomy scissors. 
One-millimeter-long aortic rings (approximately 15 per 
aorta) were sectioned and extensively rinsed in DMEM. 
Ring-shaped explants of mouse aorta were then embed-
ded in collagen gels prepared by mixing eight volumes 
of Cellmatrix type 1-A (Nitta Gelatin), one volume of 
10 × M199 medium, and one volume of 2.2% NaHCO3. 
The collagen gels containing the aortic rings were po-
lymerized by incubation at 37°C for 30 min.  Each dish 
contained 300 µl of DMEM containing 50 ng/ml human 
VEGF-A (R&D systems, Minneapolis, MN, USA).  The 
cultures were kept at 37°C in a humidified environment 
for one week and examined using a microscope (BioR-
evo, Keyence).
Results
Generation of Flk1-GFP BAC transgenic mice
We previously generated Flk1-GFP knock-in animals 
that carried a gene encoding GFP in the first exon of 
Flk1[3].  GFP expression recapitulated that of endoge-
nous FLK1 protein expression from the time point cor-
responding to the onset of FLK1 expression and there-
after.  This knock-in mouse is a useful mouse model for 
monitoring Flk1 gene activity during development and 
in the adult [3, 10].  However, the level of FLK1 expres-
sion is only half of that observed in wild-type animals 
because one of the two alleles is replaced by the cDNA 
encoding GFP [3].  Haplo-insufficiency of Flk1 could 
theoretically have phenotypic consequences, although 
we note that the Flk1-GFP knock-in mice are fertile and 
do not show any apparent vascular anomalies [3].  Kap-
pel and coworkers showed that the Flk1 promoter region 
and the enhancer within the first intron can be exploited 
to monitor the distribution of Flk1 expression [7].  The 
transgenic animals exhibited fluorescence in endothe-
lial cells during development and in the adult [7].  How-
ever, the transgene used contains only part of the Flk1 
regulatory sequence and its enhancer activity is moder-
ate (M. E., unpublished observation).  Therefore, in this 
study we aimed to generate a new animal model of Flk1 
gene expression.  We used a BAC clone that carries the 
whole Flk1 genomic region as well as the upstream and 
downstream regions (Fig. 1).  GFP cDNA was introduced 
into the first exon of the Flk1 gene in the BAC clone 
using the RED/ET recombination technique (Fig. 1).  The 
resulting GFP-carrying BAC was injected into pronuclei 
so as to create Flk1-GFP BAC Tg animals.  Five out of 
nine lines showed clear GFP fluorescence within new-
born skin and at the tip of the adult tails (Fig. 1).
Expression of GFP recapitulated by Flk1-GFP BAC Tg
We observed strong and uniform fluorescence in en-
dothelial cells at 8.5 dpc in three transgenic animals 
when we examined three transgenic lines which showed 
fluorescence within newborn skin and at the tip of the 
adult tails, indicating efficient recapitulation of the pat-
tern of endogenous Flk1 expression in endothelial cells 
at that stage (Fig. 2).  Thereafter, we characterized two 
Flk1-GFP BAC Tg mice, lines 244 and 270.  Immuno-
histochemical analysis revealed that the distribution of 
GFP expression corresponded almost exactly with that 
of endogenous FLK1 within the endothelial cells includ-
ing those of the dorsal aorta (Fig. 2).  Analysis of the 
two independent transgenic lines (lines 244 and 270) at 
8.5 dpc revealed that most if not all GFP expression 
overlapped with that of the endogenous FLK1 protein 
(Fig. 2).  These Tg embryos also showed strong GFP 
expression whose distribution was similar to that of en-
dogenous FLK1 protein at later stages, such as 9.5 dpc 
(Fig. 3).  Confocal microscopy was used to investigate 
whether the distribution of GFP expression overlapped 
with that of endogenous FLK1 in the yolk sac region of 
9.5 dpc embryos.  Analysis of the two independent trans-
618 H. ISHITOBI, ET AL.
genic lines at 9.5 dpc revealed that most if not all GFP 
expression overlapped with that of the endogenous FLK1 
protein (Fig. 4).  GFP expression was also observed 
within the blood vessels of adult skin (Fig.5), indicating 
that GFP fl uorescence in Flk1-GFP BAC Tg animals 
recapitulate endothelial expression of FLK1 from the 
embryonic stages to the adult.
Expression of GFP in the aortic ring assay
We next subjected the Tg mice to the aortic ring assay, 
which measures angiogenic activity, in particular the 
sprouting process.  A piece of aorta from an adult was 
cultured in type IV collagen matrix and endothelial 
sprouts were observed in the presence of VEGF-A.  GFP 
positive endothelial sprouts from the aortic ring were 
observed in real time (Fig. 6, data not shown).  Immu-
nohistochemical analysis using anti-FLK1 antibody 
showed that GFP protein expression completely over-
lapped that of the endogenous FLK1 protein (Fig. 6).
Taken together, these results suggest that the genom-
ic region on the BAC clone is capable of recapitulating 
the distribution of the transgene expression, mirroring 
that of endogenous Flk1 expression, and that the Flk1-
GFP BAC transgenic mice generated in this study should 
be useful for studying vascular development and patho-
logical angiogenesis.
Discussion
Flk1 plays essential roles in vasculogenesis and an-
giogenesis during development, as well as in the patho-
logical angiogenesis that occurs during tumor growth 
[5].  Therefore, there is a need for animal models that 
can faithfully monitor Flk1 gene activity.  Although two 
genetically engineered mouse strains have previously 
been described that can monitor Flk1 gene activity, there 
Fig. 1. Generation of Flk1-GFP BAC Tg mice.  (A) Schematic representation of the Flk1-GFP BAC transgene used in 
this study.  The Flk1 BAC clone (RP24-125B24) carries 22 kb and 100-kb upstream and downstream genomic 
regions, respectively.  The BAC transgene without PGK-gb2-neo cassette was used to generate transgenic animals. 
(B) Gross appearance of Flk1-GFP BAC Tg mice.  Bright fi eld (Left column) and GFP fl uorescence images (Right 
column).  Note that the GFP signal is seen throughout the entire bodies of newborn mice (P0).  (C) Genotyping of 
Flk1-GFP BAC Tg mice.  The BAC Tg mice were generally genotyped based on fl uorescence of the tail.
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Fig. 2. GFP expression in Flk1-GFP BAC Tg embryos at 8.5 dpc.  Fluorescent images of two independent 
Flk1-GFP BAC Tg and Flk1-GFP knock-in embryos at 8.5 dpc (A).  Overlapping distribution of 
the expression of GFP and endogenous FLK1 protein (B).  Section indicated in (A) was subjected 
to immunohistochemical analysis with anti-GFP and anti-FLK1 antibodies to further compare the 
distribution of their expression.
Fig. 3. Comparison of GFP expression in Flk1-GFP BAC Tg and Flk1-GFP knock-in embryos at 9.5 dpc. 
Higher magnifi cation of the head region, intersomitic vessels and the yolk sac.
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Fig. 4. Overlapping distribution of expressions of GFP and endogenous FLK1 protein in the yolk sac of 
Flk1-GFP BAC Tg embryos at 9.5 dpc.  Confocal microscopy was used to observe GFP and FLK1 
expression.
Fig. 5. Expression of GFP in the skin of adult Flk1-GFP BAC Tg mice.  Note that two independent Flk1-GFP 
BAC Tg mice showed comparable GFP expression with that of Flk1-GFP knock-in mice.
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are advantages and disadvantages in the use of these 
strains.  Flk1-GFP knock-in mice were generated by 
introducing a GFP cDNA into the fi rst exon of the Flk1 
gene [3].  While endogenous Flk1 expression was faith-
fully recapitulated in this strain, one of the two Flk1 
alleles was destroyed, raising a concern that haplo-in-
suffi ciency of the Flk1 gene may create a phenotype [3]. 
On the other hand, another strain of Flk1-lacZ trans-
genic mice, carrying the promoter and fi rst intron en-
hancer of the Flk1 gene, also recapitulated endothelial 
expression of the FLK1 gene.  Although its expression 
is relatively moderate and mosaic, raising a concern that 
all the FLK1-positive cells are not necessarily labeled 
with LacZ [7, M. E. unpublished].  Given that uniform 
and strong GFP expression was detected and that both 
Flk1 alleles are intact in the Flk1-GFP BAC transgenic 
animals generated in this study, they should prove to be 
a useful animal model.
Angiogenesis during development is a complex pro-
cess.  The early blood vessels of the embryo and yolk 
sac in mammals develop by aggregation of angioblasts 
into a primitive vascular plexus, then undergo a complex 
remodeling process, whereby growth, migration, sprout-
ing and pruning lead to the development of a functional 
circulatory system [5].  Tumor angiogenesis is also a 
complex process.  A specialized subtype of endothelial 
cell known as the tip cell is believed to be involved in 
angiogenesis, but the molecular signaling pathways uti-
lized by tip cells remain largely uncharacterized [6]. 
Since Flk1-GFP BAC transgenic animals can recapitu-
late strong and uniform GFP expressions in endothelial 
cells, they will be useful for noninvasively visualizing 
endothelial cells in the process of growth, migration, 
sprouting and pruning, and tip cell formation, at single 
cell resolution, during development and in in vitro an-
giogenesis models.
In conclusion, the Flk1-GFP BAC transgenic animals 
generated in this study should be useful in the study of 
molecular and cellular mechanisms of vascular develop-
ment and pathological angiogenesis, and may provide 
opportunities to develop new anti-angiogenic agents.
Fig. 6. GFP expression in aortic rings from Flk1-GFP BAC Tg (line 244) mice.  Aortic rings 
were dissected from Flk1-GFP BAC Tg mice and were cultured in the presence of 
VEGF-A for 4 days.  Endothelial sprouts were fi xed and immunostained with anti-GFP 
antibody.
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